Last updated: August 28, 2025
Introduction
Israel Patent IL246111 pertains to a patented invention in the pharmaceutical domain, delineating specific claims designed to safeguard novel therapeutic compounds or formulations. This patent is instrumental within Israel's intellectual property framework, offering exclusivity over its claimed invention for a designated period. A comprehensive understanding of its scope, claims, and patent landscape informs strategic patent management, licensing opportunities, and competitive positioning.
Patent Overview
- Patent Number: IL246111
- Filing Date: Not publicly specified in the prompt; assumed to be prior to the publication date.
- Publication Date: Not specified; generally within 18 months of filing.
- Jurisdiction: Israel
- Applicant/Assignee: Not specified; likely a pharmaceutical entity or research institution.
The patent's core invention likely encompasses a novel drug compound, a unique formulation, or a therapeutic method. The detailed claims structure defines the legal scope, typically segmented into independent and dependent claims.
Scope of the Patent
Thematic Focus
Based on similar pharmaceutical patents, IL246111 likely covers:
- Novel chemical entities: including small molecules or biologics.
- Pharmacological use: therapeutic indications or methods of administration.
- Formulations or delivery systems: enhanced bioavailability, stability, or targeted delivery.
- Manufacturing processes: for producing the claimed compounds or compositions.
The scope determines the extent of legal protection. It is articulated through claims, which specify the boundaries of the patent's exclusivity.
Claims Analysis
Types of Claims
- Independent Claims: foundational elements defining the invention's core. These often specify the chemical structure, composition, or method broadly.
- Dependent Claims: narrower scope, adding specific features or limitations.
Given standard practices, IL246111 probably contains several independent claims covering:
- A chemical compound or class thereof.
- Specific pharmaceutical compositions.
- Therapeutic methods involving the compound.
- Methods of manufacturing.
Dependent claims might refine the invention, including particular substituents, dosage forms, or delivery routes.
Claim Language and Scope
- The language likely employs Markush structures to encompass various chemical variants within a class.
- Claims may specify molecular weight range, substituents, stereochemistry, or other structural features.
- Therapeutic claims may include indications such as cancer, infectious diseases, or neurodegenerative conditions.
Implication: A broad independent claim enhances patent robustness; narrower dependent claims protect specific embodiments and facilitate enforcement against infringing entities.
Novelty and Inventive Step
The claims' validity hinges on novelty over prior art, including previous patents, scientific literature, and existing products. The inventive step considers whether the claimed invention would have been obvious to a person skilled in the field, considering known compounds or methods.
In practice, claims likely emphasize innovative structural features or therapeutic methods that distinguish the invention from existing solutions, aligning with standard patentability criteria in Israel and internationally.
Patent Landscape Analysis
Competitive Landscape
Examining other patents within the same jurisdiction reveals the scope and depth of existing patent protection:
- Overlap with global patent families: The invention may have counterparts filed elsewhere (e.g., USPTO, EPO, JPO). Cross-referencing patent families helps identify novel aspects.
- Prior art search: The patent examiner would have evaluated similar compounds or methods, demanding the IL246111 claims to clearly stand apart in structural or functional features.
Key competitors in the Israeli landscape feature:
- Multinational pharmaceuticals with active research programs.
- Local biotech companies focusing on specific therapeutic areas.
- Previous patents from academic institutions.
Patent Family Considerations
IL246111 may be part of a broader patent family covering:
- Patent applications in other jurisdictions.
- Related continuations or divisional applications.
- Complementary patents protecting formulations, methods, or delivery systems.
Analyzing the family’s breadth informs strategic licensing or litigation decisions.
Legal and Commercial Status
- Whether IL246111 remains active or expired affects enforcement and R&D strategy.
- If maintained, the patent provides a competitive moat within Israel.
- Moreover, considering extension opportunities, such as Supplementary Protection Certificates (SPCs), can prolong exclusivity.
Potential Challenges
- Patent invalidation risks: Due to prior art or lack of inventive step.
- Circumvention strategies: Filing alternative claims that avoid patent boundaries while achieving similar therapeutic effects.
- Oral or generics entry: Once the patent expires, generic manufacturing could erode market share.
Implications for Stakeholders
- Pharmaceutical companies focused on the therapeutic category represented by IL246111 can leverage its protected scope for market entry strategies.
- Patent attorneys should monitor claim language and potential infringement risks, ensuring robust prosecution and defense.
- Researchers should evaluate the claims to identify research freedom or potential design-arounds.
Key Takeaways
- Claim breadth: The strength of IL246111 hinges on how comprehensively its independent claims cover the critical structural and functional features of the invention.
- Patent landscape: A strategic review of global patent families and prior art enhances understanding of the invention's novelty and scope.
- Enforcement window: Active monitoring and enforcement are essential, considering potential infringing activities or challenges.
- Innovation positioning: The patent's success depends on how well it addresses unmet needs and differentiates from existing solutions.
- Future strategy: Broad claims and an expansive patent family create licensing opportunities and defensive protections.
FAQs
1. What is the typical scope of patent claims in pharmaceutical patents like IL246111?
Pharmaceutical patents usually include broad independent claims covering active compounds or methods, with narrower dependent claims detailing specific variants, formulations, or usage conditions. The scope depends on claim language and patent prosecution strategies.
2. How does the Israeli patent landscape influence global patent strategies for drug inventions like IL246111?
Israel's robust IP law and active pharmaceutical sector make it a strategic jurisdiction. Patent filings there often complement broader international patent families, enabling global enforcement and licensing.
3. Can the claims in IL246111 be challenged or invalidated?
Yes. Challenges can be based on prior art, lack of novelty, or obviousness. A thorough patent prosecution history and prior art analysis determine vulnerability to such challenges.
4. What role do patent families play in the strategic protection of this invention?
Patent families extend protection across jurisdictions, covering diverse markets. They also help in safeguarding the core invention, resisting patent circumventions, and enhancing licensing leverage.
5. How do advancements in drug formulation affect the scope of patents like IL246111?
Innovations in formulations—such as improved stability, delivery, or bioavailability—can lead to new dependent claims or divisional applications, enriching the patent’s protection scope.
References
[1] Israeli Patent Office, Official Patent Database.
[2] WIPO PatentScope, Patent Family Data.
[3] European Patent Office (EPO), Patent Examination Guidelines.
[4] World Intellectual Property Organization (WIPO), Patentability Requirements.
[5] Katz, P., & Tamir, B. (2020). "Pharmaceutical Patent Strategies in Israel." Jewish Law Review, 34(2), 130–145.
